Inovise Medical to Present at Medtech Insight and Windhover Information's 'In3 East' Investor Conference in Boston, October 19, 2006.

The Company's AUDICOR([R]) Product Line Provides the Only Low Cost, Fast Non-Invasive Test to Reliably Evaluate the Heart's Hemodynamic Performance without the Need for Expensive Equipment or Specialized Technicians

BOSTON -- Inovise Medical (www.audicor.com) announced today they will present at Medtech Insight and Windhover Information's aIn3 East' Investor Conference on October 19, 2006, at The Westin Hotel, Copley Place, Boston, MA.

The company's flagship AUDICOR([R]) product line is the pioneer in Acoustic Cardiography, a new technology category used to diagnose heart failure, identify dysfunction severity, and evaluate treatment in a variety of clinical settings. Acoustic Cardiography leverages two established parameters: the electrocardiogram (ECG), the most common diagnostic test worldwide; and heart sounds, which have long been recognized as providing clinically actionable information to health care providers. AUDICOR([R]) uses two small patented and proprietary sensors, the first of its kind, to analyze the electro-mechanical heart function from 10 seconds of ECG and acoustic heart sound data. AUDICOR([R])'s patented signal processing simultaneously detects and interprets the incoming cardiac information. Results are immediately displayed on-screen and in a simple, single-page report. AUDICOR([R]) technology can be deployed flexibly, either through a small dedicated device that fits easily into existing clinician workflow and environments, or through integration into OEM devices through our partnership agreements.

More than 50 peer-reviewed publications in leading scientific medical journals (including the Journal of the American Medical Association, Congestive Heart Failure, the American Journal of Emergency Medicine, and Archives of Internal Medicine) have demonstrated AUDICOR([R])'s ability to accurately assess hemodynamic function and the strong correlation between AUDICOR([R]) measurements and high-end tests such as angiography and echocardiography. Through these publications, the medical community is learning how to easily incorporate AUDICOR([R]) into their evidence-based medical practices.

Heart failure is a growing epidemic in the United States, with 550,000 new cases reported each year, according to recent statistics from the American Heart Association, and 5 million currently diagnosed. It represents the single most expensive disease both for Medicare and for most private payers. Consequently, there is a large clinical need and growing awareness of the financial impact of this disease.

For additional information, visit the Inovise Medical website at www.audicor.com.